Appendix 8
Serum Iodine Levela io Marshallese, 1959-1974
Key:

Subject
No. & sex

Age at
exposure

Diagnosis

Plain cumbera are Ty, values; arrow indicates change in T, with TSH;

TSH = thyroid stimulating hormone; numbers in parentheses are PBI values;
S indicates surgery; TR indicates beginning of hormone treatment.

TR

1958-61

1962

(8.1)

(7.4)

(8.8)

{7.2)

(1.9)

(1.4)
1.3

(3.2)
1.6

5.9

2.0

3.3

(0.6)
3.1

(4.6)

(2,5)

(2.5)

(3.1)

1.48

1.6

1.6

(0.8)

(7.0)

2.9
(6.2)
(5.6)

1963

1964

1965

1966

1967

1968

1969

1970

1971

1972

1973

1974

Rongelap Exposed With Thyroid Lesions

83

M

3

M

1

Myxedema

5

M

1

Myxedema

33

54

F

M

In utero Benign
(2nd tri) adenomas

1

1

.

(6.6)

Benign
adenomas

(7.1)

Benign
adenomas

(7.8)

65

F

1

Beniga

(7.1)

2

=#sM

2

Benigno

(8.0)

adenomas

(6.7)

(1.9)

=F

3

(8.8)

(7.1)

M

3

Benign

(6.4)

21

=F

3

Benign

(6.8)

(7.4)

3

Benign

23

M

4

Benign
adenomas

(2.3)

(7.7)
(8.8)

(9.6)

(9.0)

3.7

(6.1)

9.6

(8.7)

(7.9)

16.9

(10.7)

10.5

12.06

5.0

7.8

4.2

2.3

4.2

5.7

4.2

9.6

9.0

(7.7)

5.4

(1.3)

2.6

s
1.3

(7.8)

(8.7)

72,

OF

6

Carcinoma

(8.2)

(3.3)

15

F

?

Benign
adenomas

(12.8)

(6.4)

20

M

?

Benign
adenomas

(7.0)

Benign
adenomas

(10.6)
(11.4)

(5.5)

(2.7)
:

(11.5)

(10.2)

5

(7.1)

7.8

16.1

(7.2)
(6.1)

6.8
(4.1)

61

F

8

Benign
adenomas

75

OF

12

Benign
adenomas

(4.7)

67

F

14

(6.6}

18

F

21

Nodule
0.5 co,
lt. lobe
Carcinoma

9.1

(8.2)

16.9

(14.1)

11.4

11.9

7.3

2.3

6.5

40

M

29

Benign
adenomas

64

F

30

Carcinoma

(10.7)

56

F

66

Benign

Died 62

10.3

(7.3)

4.9

6.0

6.3

10.7

(6.4)

{10.0)

(9.5)
6.3 S
8.0

(4.2)
(4.2)

4.2

4.2

7.0

(8.3)
7.59) 5

7.3,8.0

(4.5)

(7.5) §
5.5

3.3

adenomas

- lll -

2.7
TSH 12.5

0

3.3

3.6

TSH 1.7

3.7
TSH 6.8

10,1
TSH 32.0

7.4

6.5
TSH 8.2

TSH 215

14.9

1.0

TSH 243

1.7

TSH 118

15.3

23.2

15,1

(0.6)
3.3

(7.9)
7.7

20.3

13.4

TSH 32

12.6+14.3

19.9

TSH 1.3

11.9

15.8

10.1

2.8
5.1
TSH 81.0 TSH 62
9.8

TSH<2.5

1.3,0.3

0.2
TSa~200
8.6

3.6

TSH 3.4

TSH<2.5

13.8
TSH<1

6.6

0

TSH 49

6.9

TSH<1L
12.4
TSH 1.1
17.4

TSH<L
7.8
TSE 16
11.1

TSsa LO

<0.4

TSH 116

7,7
TSH 9.2

11.3

9.8
TSH<1
8.9
TSH<1

(2.8)

14.0

7.0
TSR 2.7

13.9

4.6
(3.8)

4.9,6.7
5.0

10.0
TSH<2.5

2.5
TSH 59

(11.6)
6.2

(3.9)
6.3

16.0

12.4

4.4

4.6
TSH 2.8

(8.1)

(10.0)

18.9

22.0
23.3

23.90
TSH 5.6

(6.8)

(9.1)

11.9

9.6

7.4
TSH 2.7

15.5
(10.7)

9.9

0.4
TSH 110

12.7

7.2
TSH<2.5

4,2

s

6.3
10.2 §

(10.3)

(12.0)

$

3.9
1.6

TSH 36.6

§

(11.7)

(7.0)

6.3

(4,2)

6.1

(5.7)

(2.8)
2.8

8.9

TSH<2.5

8.5

9.8

3.7

Benign

6.2+8.6
TSH 7.0 S$

TSH 79.0 TSH 376

Died Nov 72
1.8

15.9

(6.5) §
7.8,7.3

(10.3)

6.7

TSH 2.0

(5.0)

4

7

7.5

<0.8

F

OM

5

(1.8)

(0.7)

69

36

7.9

5
(12.2)

2.5

1.6

TSH 163
22.3

$

3.3

(8.1)

9.3

6.7
TSH<2.5

<0.8

Ss

adenomas

adenomas

6.6
(5.2)
§

(5.6)

(4,1)

adenomaas
F

(5.1)

s

19

62

(3.1)

(7.9)

adenomas

adenomas

(5.0)
7.0

(7.0)

(6.2)
6.8

10.3

3.3

5.9,4.1
12.5
TSH &1
1.3

§

7.3,5.01

3.1+7.6

(10.2)

Benign

(2.1)

(8.3)

adenomas

17

7.5

9.0

13.0

2.9

(10.3)

6.8

§.0

(7.0)

12.4

TSH 24

8.6

S$
6.5
TSH 1.35

7.6

TSH> 60;
172

17.8

7,0
9.6 S
10.6

1.3
TSH 15

10.9
TSH<1
7.8
TSE 2.6
9.07.5

TSH 1.2

Select target paragraph3